News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Vivo Capital IX, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Bought 3,157,894 shares
@ $1.9, valued at
$6M
Bought 3,157,894 warrants
@ $2.47, valued at
$7.8M
|
|
| 07/01/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 161,712 shares
@ $55, valued at
$8.9M
Disposed/sold 2,735,853 shares
@ $55, valued at
$150.5M
Disposed/sold 431,947 shares
@ $55, valued at
$23.8M
Disposed/sold 324,740 options to buy
@ $13.2, valued at
$4.3M
Disposed/sold 1,455,384 options to buy
@ $13.2, valued at
$19.2M
Disposed/sold 75,749 options to buy
@ $13.2, valued at
$999.9k
|
|
| 05/04/2022 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 41,800 shares
@ $15.19, valued at
$634.9k
Sold 451,418 shares
@ $13.25, valued at
$6M
Sold 19,738 shares
@ $12.67, valued at
$250.1k
|
|
| 01/31/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Bought 800,000 shares
@ $27, valued at
$21.6M
|
|
| 01/28/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Exercised (in-or-at-the-money) 75,749 options to buy
@ $13.2, valued at
$999.9k
Exercised (in-or-at-the-money) 1,455,384 options to buy
@ $13.2, valued at
$19.2M
Exercised (in-or-at-the-money) 324,740 options to buy
@ $13.2, valued at
$4.3M
|
|
| 11/12/2021 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Converted 2,365,545 shares
@ $0
Bought 650,000 shares
@ $14, valued at
$9.1M
Converted 188,168 preferred shares
@ $0 |
|
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2020 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Converted 2,780,754 shares
@ $0
Converted 214,281 shares
@ $0
Bought 250,000 shares
@ $16, valued at
$4M
Converted 2,780,754 preferred shares
@ $0
Converted 214,281 preferred shares
@ $0 |
|
| 07/21/2020 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC|
Txns:
| Bought 789,474 shares
@ $19, valued at
$15M
Converted 3,245,048 shares
@ $0
Bought 185,526 shares
@ $19, valued at
$3.5M
Converted 3,158,851 convertible preferred
@ $0 |
|
| 01/31/2020 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Converted 75,759 shares
@ $0
Converted 1,455,576 shares
@ $0
Converted 324,783 shares
@ $0
Converted 1,000 options to buy
@ $0
Converted 19,213 options to buy
@ $0
Converted 4,287 options to buy
@ $0 |
|
|
|